Cerity Partners LLC Madrigal Pharmaceuticals, Inc. Transaction History

Cerity Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$193.33 - $291.99 $1,353 - $2,043	-7 Reduced 0.61%	1,135 $317,000
Q1 2024 May 14, 2024	BUY	$171.37 - $283.23 $195,704 - $323,448	1,142 New	1,142 $304,000
Q1 2023 May 11, 2023	BUY	$231.06 - $307.08 $20,564 - $27,330	89 Added 10.79%	914 $221,000
Q4 2022 Feb 15, 2023	BUY	$58.39 - $296.54 $48,171 - $244,645	825 New	825 $239,000

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.